Indoco launches FEVINDO 400 – Favipiravir 400mg Tablets

Mumbai, Sep 28 (UNI) Pharma Major, Indoco Remedies said that company has launched FEVINDO (Favipiravir) 400 mg Tablets in India. Fevindo – 400 (Favipiravir) is an antiviral drug, effective against the RNA-based influenza virus. The drug has been approved by DCGI in the treatment of Covid-19. Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient compliance, company said in a filing with BSE.

Ms Aditi Kare Panandikar, Managing Director – Indoco Remedies Ltd. commented, “The Covid-19 crisis has created vast disruption to life in India and all over the globe. As part of pharma industry, we have been able to do our bit in prevention of Covid-19 with our brands Karvol Plus, ATM, Febrex Plus and Rexidin SRS Mouthwash. With the launch of FEVINDO, we are taking the next step from prevention to the treatment of Covid-19.”


Please enter your comment!
Please enter your name here